Skip to main content

Day: August 7, 2020

Senvest Capital Inc. annonce ses rėsultats pour le trimestre terminé le 30 juin 2020

MONTRĖAL, 07 août 2020 (GLOBE NEWSWIRE) — Senvest Capital Inc. a annoncé aujourd’hui un résultat net attribuable aux actionnaires ordinaires de 161,2 M$ ou 60,85$ par action pour les trois mois terminés le 30 juin 2020. Pour la période correspondante de 2019, elle avait inscrit un résultat net attribuable aux actionnaires ordinaires de (56,6) M$ ou (21,04) $ par action.  Pour les six mois terminés le 30 juin 2020, le résultat net attribuable aux actionnaires ordinaires était de (180,7) M$ ou (68,53) $ par action comparée à un résultat net attribuable aux actionnaires ordinaires de (1,8) M$ ou (0,67) $ par action l’année précédente.Les états financiers sont disponibles sur le site Sedar www.sedar.comGeorge Malikotsis, Vice Président, FinanceTel: (514) 281-8082

Continue reading

Passage Bio to Report Second Quarter 2020 Financial Results on August 13, 2020

PHILADELPHIA, Aug. 07, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that it will host a conference call and live webcast at 8:30 a.m. ET, Thursday, August 13, 2020 to report its second quarter 2020 financial results and discuss recent business highlights.To access the live conference call, please dial 833-528-0605 (domestic) or 830-221-9711 (international) and refer to conference ID 5679946. A live audio webcast of the event will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. The archived webcast will be available on Passage Bio’s website approximately two hours after the completion of the event and for 30 days...

Continue reading

BowX Acquisition Corp. Announces Closing of $420,000,000 Initial Public Offering

Menlo Park CA, Aug. 07, 2020 (GLOBE NEWSWIRE) — BowX Acquisition Corp. (the “Company”) announced today that it closed its initial public offering of 42,000,000 units at $10.00 per unit. The offering resulted in gross proceeds to the Company of $420 million.The Company’s units are listed on The Nasdaq Capital Market (“Nasdaq”) and commenced trading under the ticker symbol “BOWXU” on August 5, 2020. Each unit consists of one share of the Company’s Class A common stock and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment. Only whole warrants are exercisable and will trade.  Once the securities comprising the units begin separate trading, shares of the Class A common stock and redeemable warrants are...

Continue reading

Baltic Horizon Fund Consolidated Unaudited Interim Results for H1 2020

Management Board of Northern Horizon Capital AS (the Management Company) has approved the unaudited consolidated interim financial statements of Baltic Horizon Fund (the Fund) for the first six months of 2020.Impact of COVID-19 pandemicAt the beginning of 2020, a new coronavirus (COVID-19) started spreading all over the world, which has had an impact on businesses and economies, including in the Baltics.It is evident that the operating results of Q2 2020 and property valuations were affected by the COVID-19 effects on the tenants’ financial performance and relief measures taken to deal with the pandemic. However based on the currently available information, the Management Company believes that the COVID-19 pandemic should rather have a temporary effect on the Fund’s results and less than was previously expected. Broad portfolio diversification...

Continue reading

Baltic Horizon Fund Consolidated Unaudited Interim Results for H1 2020

Management Board of Northern Horizon Capital AS (the Management Company) has approved the unaudited consolidated interim financial statements of Baltic Horizon Fund (the Fund) for the first six months of 2020.Impact of COVID-19 pandemicAt the beginning of 2020, a new coronavirus (COVID-19) started spreading all over the world, which has had an impact on businesses and economies, including in the Baltics.It is evident that the operating results of Q2 2020 and property valuations were affected by the COVID-19 effects on the tenants’ financial performance and relief measures taken to deal with the pandemic. However based on the currently available information, the Management Company believes that the COVID-19 pandemic should rather have a temporary effect on the Fund’s results and less than was previously expected. Broad portfolio diversification...

Continue reading

BALTIC HORIZON FONDI 2020. AASTA I POOLAASTA KONSOLIDEERITUD AUDITEERIMATA MAJANDUSTULEMUSED

Northern Horizon Capital AS-i (Fondivalitseja) juhatus on kinnitanud Baltic Horizon Fondi (Fond) auditeerimata konsolideeritud vahearuande tulemused 2020. aasta esimese kuue kuu kohta.COVID-19 pandeemia mõju2020. aasta alguses hakkas kõikjal maailmas levima uus koroonaviirus (COVID-19), mis on mõjutanud erinevate riikide, sh Balti riikide, ettevõtteid ja majandust. On ilmne, et Fondi 2020. aasta II kvartali majandusnäitajaid ja kinnisvarainvesteeringute hindamistulemusi mõjutasid viirusepuhangu mõju rentnike finantstulemustele ja pandeemia tõttu rakendatud leevendusmeetmed. Praegu saadaoleva informatsiooni alusel usub Fondivalitseja siiski, et COVID-19 pandeemia avaldab Fondi tulemustele pigem ajutist mõju ning vähem, kui algselt arvati. Hästi hajutatud portfell peaks võimaldama Fondil COVID-19 mõju piirata ja jätkuvalt korralikke konsolideeritud...

Continue reading

Nasdaq Scheduled Resumption in SCWorx Corp.

NEW YORK, Aug. 07, 2020 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading in SCWorx Corp. (Nasdaq: WORX) is scheduled to resume on Monday, August 10, 2020, at 7:00 a.m. Eastern Time.  Trading in the company’s stock was halted on April 22, 2020 at 9:25:05 a.m. Eastern Time.For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.NDAQONasdaq Media Contact:Bianca FataBianca.Fata@nasdaq.com

Continue reading

STACR REMIC Trust Notes Receive NAIC Price Breakpoints

McLEAN, Va., Aug. 07, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today announced that its STACR® (Structured Agency Credit Risk) REMIC Trust 2019-DNA4 notes have received National Association of Insurance Commissioners (NAIC) price breakpoints for the 2019 filing year.  Freddie Mac engaged NAIC Structured Securities Group (SSG) to evaluate STACR REMIC Trust transactions issued in 2019 and STACR Trust (DNA/HQA) transactions issued in 2018 and 2019 for year-end 2019. The year-end 2019 results of NAIC Structured Securities Group (SSG) analysis for STACR REMIC Trust 2019-HQA4 is expected within the next few weeks. NAIC Structured Securities Group (SSG) is also in process of evaluating the 2018 and 2019 STACR Trust (DNA/HQA) transactions.The 2019-DNA4 offering was Freddie Mac’s first STACR REMIC Trust structure. In a STACR REMIC...

Continue reading

Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

REDWOOD CITY, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) announces that the U.S. Food and Drug Administration (FDA) has approved Guardant360® CDx for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients with any solid malignant neoplasm (cancerous tumor). The Guardant360 CDx is also approved as a companion diagnostic to identify non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) alterations who may benefit from treatment with Tagrisso® (osimertinib). Guardant360 CDx offers patients and clinicians a simple, faster blood test to help inform personalized treatment options.The Guardant360 CDx FDA approval was based on clinical and analytical validation data from over 5,000 samples. In a retrospective analysis of data from pivotal phase...

Continue reading

Vistas Media Acquisition Company Inc. Commences Trading of $100 Million IPO on Nasdaq

New York , Aug. 07, 2020 (GLOBE NEWSWIRE) — Vistas Media Acquisition Company Inc. (Nasdaq: VMACU) (“VMAC” or the “Company”), a blank check company, also commonly referred to as a Special Purpose Acquisition Company, or SPAC, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, commenced trading today of its $100 million initial public offering on The Nasdaq Stock Market. The offering consists of 10,000,000 units at a price to the public of $10.00 per unit. About Vistas Media Acquisition Company Inc.VMAC, led by CEO F. Jacob Cherian and Co-Founders Abhayanand Singh and Saurabh Gupta, is a blank check company, also commonly referred to as a Special Purpose Acquisition Company, or SPAC, formed for the purpose...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.